RK-33 binds to the ATPase domain of DDX3 and is reported to improve radiation sensitisation of tumours in models of lung cancer, colorectal cancer, prostate cancer and Ewing’s carcinoma27,28,40–44. This evidence concerns the gene DDX3X and neoplasm.